title: Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation.
authors: Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central, Melbourne Victoria 8008, Australia. markus.schlaich@bakeridi.edu.au.
authors: Markus P
authors: MP
authors: Schlaich
authors: Murray D
authors: MD
authors: Esler
authors: Greg D
authors: GD
authors: Fink
authors: John W
authors: JW
authors: Osborn
authors: David E
authors: DE
authors: Euler
mesh_terms: D000818:Animals; D001794:Blood Pressure; D003714:Denervation / Q000379:methods*; D006801:Humans; D006973:Hypertension / Q000503:physiopathology / Q000601:surgery*; D007668:Kidney / Q000294:innervation*; D018579:Patient Selection; D013564:Sympathetic Nervous System / Q000503:physiopathology* / Q000601:surgery; D016896:Treatment Outcome